Skip to main content
Erschienen in: Infection 5/2018

05.06.2018 | Original Paper

Prolonged antibiotic prophylaxis after thoracoabdominal esophagectomy does not reduce the risk of pneumonia in the first 30 days: a retrospective before-and-after analysis

verfasst von: Marcel Hochreiter, Maria Uhling, Leila Sisic, Thomas Bruckner, Alexandra Heininger, Andreas Hohn, Katja Ott, Thomas Schmidt, Marc Moritz Berger, Daniel Christoph Richter, Markus Büchler, Markus Alexander Weigand, Cornelius Johannes Busch

Erschienen in: Infection | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Thoracoabdominal esophageal resection for malignant disease is frequently associated with pulmonary infection. Whether prolonged antibiotic prophylaxis beyond a single perioperative dose is advantageous in preventing pulmonary infection after thoracoabdominal esophagectomy remains unclear.

Methods

In this retrospective before-and-after analysis, 173 patients between January 2009 and December 2014 from a prospectively maintained database were included. We evaluated the effect of a 5-day postoperative course of moxifloxacin, which is a frequently used antimicrobial agent for pneumonia, on the incidence of pulmonary infection and mortality after thoracoabdominal esophagectomy.

Results

104 patients received only perioperative antimicrobial prophylaxis (control group) and 69 additionally received a 5-day postoperative antibiotic therapy with moxifloxacin (prolonged-course). 22 (12.7%) of all patients developed pneumonia within the first 30 days after surgery. No statistically significant differences were seen between the prolonged group and control group in terms of pneumonia after 7 (p = 0.169) or 30 days (p = 0.133), detected bacterial species (all p > 0.291) and 30-day mortality (5.8 vs 10.6%, p = 0.274).

Conclusion

A preemptive 5-day postoperative course of moxifloxacin does not reduce the incidence of pulmonary infection and does not improve mortality after thoracoabdominal esophagectomy.
Literatur
2.
Zurück zum Zitat Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481–8.CrossRefPubMed Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481–8.CrossRefPubMed
10.
Zurück zum Zitat WHO Guidelines Approved by the Guidelines Review Committee. Global guidelines for the prevention of surgical site infection. Geneva: World Health Organization Copyright (c) World Health Organization 2016; 2016. WHO Guidelines Approved by the Guidelines Review Committee. Global guidelines for the prevention of surgical site infection. Geneva: World Health Organization Copyright (c) World Health Organization 2016; 2016.
12.
13.
Zurück zum Zitat Wacha HIR, Kujath P, Lebert C, Naber CK, Salzberger B. Perioperative antibiotic prophylaxis. Evidence based guidelines by an expert panel of the Paul Ehrlich Gesellschaft. Chemother J. 2010;19:70–84. Wacha HIR, Kujath P, Lebert C, Naber CK, Salzberger B. Perioperative antibiotic prophylaxis. Evidence based guidelines by an expert panel of the Paul Ehrlich Gesellschaft. Chemother J. 2010;19:70–84.
15.
Zurück zum Zitat Morita M, Otsu H, Kawano H, Kumashiro R, Taketani K, Kimura Y, et al. Advances in esophageal surgery in elderly patients with thoracic esophageal cancer. Anticancer Res. 2013;33:1641–7.PubMed Morita M, Otsu H, Kawano H, Kumashiro R, Taketani K, Kimura Y, et al. Advances in esophageal surgery in elderly patients with thoracic esophageal cancer. Anticancer Res. 2013;33:1641–7.PubMed
20.
Zurück zum Zitat Ferrara AM. A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP). Clin Interv Aging. 2007;2:179–87.PubMedPubMedCentral Ferrara AM. A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP). Clin Interv Aging. 2007;2:179–87.PubMedPubMedCentral
25.
Zurück zum Zitat Edlund C, Nord CE. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora. Infection. 1988;16:8–12.CrossRefPubMed Edlund C, Nord CE. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora. Infection. 1988;16:8–12.CrossRefPubMed
29.
Zurück zum Zitat Fujita TDH. Optimal duration of prophylactic antimicrobial administration and risk of postoperative infectious events in thoracic esophagectomy with three-field lymph node dissection: short-course versus prolonged antimicrobial administration. Esophagus. 2015;12:38–43.CrossRef Fujita TDH. Optimal duration of prophylactic antimicrobial administration and risk of postoperative infectious events in thoracic esophagectomy with three-field lymph node dissection: short-course versus prolonged antimicrobial administration. Esophagus. 2015;12:38–43.CrossRef
30.
Zurück zum Zitat Sharpe DA, Renwick P, Mathews KH, Moghissi K. Antibiotic prophylaxis in oesophageal surgery. Eur J Cardio Thoracic Surg. 1992;6:561–4.CrossRef Sharpe DA, Renwick P, Mathews KH, Moghissi K. Antibiotic prophylaxis in oesophageal surgery. Eur J Cardio Thoracic Surg. 1992;6:561–4.CrossRef
39.
Metadaten
Titel
Prolonged antibiotic prophylaxis after thoracoabdominal esophagectomy does not reduce the risk of pneumonia in the first 30 days: a retrospective before-and-after analysis
verfasst von
Marcel Hochreiter
Maria Uhling
Leila Sisic
Thomas Bruckner
Alexandra Heininger
Andreas Hohn
Katja Ott
Thomas Schmidt
Marc Moritz Berger
Daniel Christoph Richter
Markus Büchler
Markus Alexander Weigand
Cornelius Johannes Busch
Publikationsdatum
05.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 5/2018
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1160-2

Weitere Artikel der Ausgabe 5/2018

Infection 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.